2006 Attendees

This is the list of companies and organisations registered to date to attend the 5th Annual North America Forum for Investing & Partnering in Biotech & Medtech.

3i
Abcam
Accelsiors Group International
Acretia, Inc.
Acretia, Inc.
Advaxis
Advent International
Aethlon Medical Inc.
Affitech AS
Agendia
Agrivida
Aisling Capital
Alexea Consulting
Allergy Therapeutics plc
Alnylam Pharmaceuticals
Alta Partners
Altius Strategy Group
American Stock Exchange
Andesite
Anglo Irish Bank
Apeiron Partners LLC
Apoxis
Apoxis
APS International Inc
Astex Therapeutics
Attogen
Avidex
BCL Capital Management
Bell Pottinger USA
Bellevue Asset Management AG
Beth Israel Deaconess Medical Center
BioAxone Therapeutic Inc
BIOCOM
BIO-IB
BIOLyNX
BioMS Medical
BioNet Holding
Biophan Technologies
BioSante Pharmaceuticals
BioStrategy Consulting Group
BioTeam Paris Region
BioVex Inc.
BlackRock Advisors
Boston Globe
Boston Life Sciences Inc.
Boston Millennia Partners
Boston University
Brigham and Women's Hospital
Brookside Capital
Bund Capital Ltd
Cadence Capital Management
Cambria Biosciences LLC
Cambridge Associates LLC
Canaccord Adams
Canadian Consulate General
Capital Advisors Group
Capital Funding
Cargill Ventures
Carrot Capital Healthcare Ventures
CBT Advisors
CDIB Bioscience Venture Management
CELLERIX
Century Capital Management, Inc.
Chemokine Therapeutics
Children's Hospital Boston
Comerica Bank
Commons Capital, LP
Compracsi Scientific Commemorations
ConjuGon, Inc.
Constitution Research & Management
Covington Associates LLC
CRESA Partners
Dana Farber Cancer Institute
Deloitte & Touch LLP
Deutsche Asset Management (DeAM)
Deutsche Bank
DeveloGen AG
DiaKine Therapeutics, Inc.
Diamyd Inc
Diamyd Medical
Edwards Angell Palmer & Dodge
EGS Healthcare
Ensemble Discovery Corporation
ESBATech
Evolutec
EXACT Sciences Corporation
Faber, Daeufer & Rosenburg
FBR Investment Management, Inc.
Feinstein Kean Healthcare
Ferghana Partners Inc
Flagship Ventures
Forenap Pharma
Gaymond International
Genfit
Genomic Healthcare Strategies
Genzyme Corporation
Genzyme Pharmaceuticals
GGA Software
Global Life Science Ventures GmbH
Global Markets Capital Group, LLC, Investment Bankers
Glycoform Limited
GSAS Harvard Biotechnology Club
Hambrecht & Quist Capital Management
Harvard Business School
Harvard Clinical Research Institute
Harvard Medical School
Harvard School of Public Health
Harvard University
Harvard University Office of Technology Development
Health Advances
Health Industry Insights, An IDC Company
Health Products Development, Inc
Henry M. Jackson Foundation
Hercules Technology Growth Capital
Hoffer Associates
Hub Investment Management Group, LLC
Hub Management Investment Group
Hunting Party Securities, Ltd
IBEX Technologies Inc
IBM Healthcare and Life Sciences
immatics biotechnologies GmbH
Inflazyme Pharmaceuticals Ltd
InForsyth
Ingenium Pharmaceuticals
Institute of Brain Research
International Finance Corp
IR Partners
Ironwood Capital Management, LLC
Isolagen Inc
Jennings Capital
Johns Hopkins University
Johnson & Johnson Development Corporation
Katan Associates International
KBL Healthcare Ventures
Knight Equity Markets, LP
LaVoie Strategic Communications Group, Inc
Lectus Therapeutics
Leerink Swann & Company
Lexitek
Life Science Advisors
Lilly Ventures
Liponex Inc
Loomis Sayles & Co
Louisiana Fund I
Manhattan Pharmaceuticals, Inc.
MASA Life Science Ventures
Mass High Tech
Massachusetts General Hospital
MassMEDIC
Matritech, Inc
MDJ Consulting
MDM Technologies
MDS Capital Corp
Meditech Research Limited
MEDRAD Inc.
Medtronic
Memorial Sloan Kettering Cancer Center
Merck & Co, Inc.
Mercury Therapeutics, Inc
Merrimack Pharmaceuticals, Inc.
Mersana Therapeutics
MFS Investment Management
Millennium
MIT Sloan School of Management
mondoBIOTECH AG
Moors & Cabot
MorphoSys AG
MPM Capital
NeuroVentures Capital LLC
New York Academy of Sciences
NGN Capital
NIF Ventures - Life Sciences
Novasite Pharmaceuticals, Inc.
Novotech
Oakes, Lyman & Co
Organon International
Organon International
Oxford Bioscience Partners
Oxford Finance Corporation
Paramount BioCapital
Paramount BioSciences
Penny Lane Partners
Perlan Therapeutics
Pfizer Global Research & Development
Predix Pharmaceuticals, Inc.
PureTech Development LLC
PureTech Development LLC
Putnam Investment Management, LLC
RA Capital Management
RCT BioVentures
RMG Associates
Rockport Venture Partners
Santhera Pharmaceuticals
Sapphire Therapeutics
Schroder Ventures Life Sciences
Scientific Legacies
Seaflower Ventures
SEPA Capital
Serono, Inc.
SHARE, Consulate of Switzerland
Sherbrook Capital Management, LLC
Sherris Pharma Partners
Shire Pharmaceutical Group
Siemens Venture Capital
SJ Berwin & Co
Sloan Securities Corp
Smart Holograms, Inc
Still River Funds
Stonecroft Capital LLC
Stressgen Biotechnologies Inc
Summit Investments
SunTrust Robinson Humphrey
SV Life Sciences
Swifton Equity Advisors
Swiss Medica
Sycamore Ventures
Targanta Therapeutics Inc.
Techno Venture Management
Temasek Holdings Ltd
The CBR Institute for Biomedical Research
The Mercury Group
The Wall Street Journal
Thermo Electron Corporation
Think Equity
ThoughtLynx
Tiger Advisors LLC
Topigen Pharmaceuticals, Inc.
Transnational Capital Copr.
Transport Pharmaceuticals
Triathlon Life Sciences
Tristate Ventures LLC
TSG Partners
Tufts University
TVM Techno Venture Management GmbH
UBS Investment Bank
UK Trade & Investment
University at Albany, SUNY
Vakzine Projekt Management GmbH
Valeo Partners
Ventac Partners
Vertex Pharmaceuticals, Inc.
VioQuest Pharmaceuticals
VIRxSYS Corporation
Wachovia Securities, Inc
Walsh Strategy Group
Warburg Pincus
Wellington Management Company, LLP
Wellington Partners Venture Capital
Westfield Capital Management
Wyeth BioPharma
Y Patent
Zealand Pharma